Comparing Annovera vs Yasmin
Annovera Remove Annovera from your drug comparison | Yasmin Remove Yasmin from your drug comparison |
---|
Annovera ethinyl estradiol / segesterone Remove Annovera from your drug comparison | Yasmin drospirenone / ethinyl estradiol Remove Yasmin from your drug comparison | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescribed for Birth Control. Annovera may also be used for purposes not listed in this medication guide. |
Prescribed for Premenstrual Dysphoric Disorder, Acne, Birth Control. Yasmin may also be used for purposes not listed in this medication guide. |
||||||||||||||||
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
|||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
See the full Annovera side effects document. |
See the full Yasmin side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Annovera prices |
View all Yasmin prices and generic prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
No |
|||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
N/A |
Other drospirenone / ethinyl estradiol brands include: Gianvi, Jasmiel, Kemeya, Kyra, Lo-Zumandimine, Loryna, Melamisa, Nikki, Ocella, Syeda, Yaela, Yaz, Zarah, Zumandimine View more | ||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
15.1 hours |
32.5 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
Summary unavailable. See the full Pregnancy Warnings document. |
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
|||||||||||||||||
N/A |
|||||||||||||||||
Drug Interactions |
|||||||||||||||||
A total of 412 drugs are known to interact with Annovera:
|
A total of 476 drugs are known to interact with Yasmin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
|||||||||||||||||
|
|
||||||||||||||||
First Approval Date |
|||||||||||||||||
August 10, 2018 |
May 11, 2001 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.